Coeptis Therapeutics Holdings Financial Overview
Coeptis Therapeutics Holdings's market cap is currently $80.80M. The company's EPS TTM is $-5.646; its P/E ratio is -3.82; Coeptis Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.